Lantern Pharma Hosts Webinar on Open‑Medicine AI Platform

What Happened
Lantern Pharma, Inc. (LTRN) filed a Form 8-K on September 24, 2026 disclosing that it hosted a live webinar on September 23, 2026 to discuss its Open‑Medicine multi‑agent AI platform for drug development. A replay of the webinar is posted on YouTube (https://youtu.be/s7br8vjMk4s) and on the company’s investor website. The presentation used in the webinar is furnished as Exhibit 99.1 to the Form 8‑K and is incorporated by reference.

Key Details

• Webinar date: September 23, 2026; Form 8‑K filed: September 24, 2026.
• Replay available: YouTube link (https://youtu.be/s7br8vjMk4s) and the investors section of www.lanternpharma.com.
• Presentation from the webinar is included in the filing as Exhibit 99.1.
• Disclosure made under Regulation FD (broad public disclosure of the information).

Why It Matters
This filing makes Lantern’s discussion of its Open‑Medicine AI platform publicly available to all investors at the same time, increasing transparency about the company’s AI-driven drug‑development approach. The 8‑K does not report financial results or personnel changes; it documents investor relations activity and provides primary materials (replay and presentation) that investors can review to assess the company’s technology strategy and progress.